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PERSPECTIVE OPEN
Improving primary care management of asthma: do
we know what really works?
Monica J. Fletcher1✉, Ioanna Tsiligianni2, Janwillem W. H. Kocks 3,4,5, Andrew Cave6, Chi Chunhua7, Jaime Correia de Sousa 8,9,
Miguel Román-Rodríguez10, Mike Thomas 11, Peter Kardos 12, Carol Stonham13, Ee Ming Khoo 14, David Leather15 and
Thys van der Molen16
Asthma imposes a substantial burden on individuals and societies. Patients with asthma need high-quality primary care
management; however, evidence suggests the quality of this care can be highly variable. Here we identify and report factors
contributing to high-quality management. Twelve primary care global asthma experts, representing nine countries, identified key
factors. A literature review (past 10 years) was performed to validate or refute the expert viewpoint. Key driving factors identified
were: policy, clinical guidelines, rewards for performance, practice organisation and workforce. Further analysis established the
relevant factor components. Review evidence supported the validity of each driver; however, impact on patient outcomes was
uncertain. Single interventions (e.g. healthcare practitioner education) showed little effect; interventions driven by national policy
(e.g. incentive schemes and teamworking) were more effective. The panel’s opinion, supported by literature review, concluded that
multiple primary care interventions offer greater benefit than any single intervention in asthma management.
npj Primary Care Respiratory Medicine           (2020) 30:29 ; https://doi.org/10.1038/s41533-020-0184-0
INTRODUCTION
Asthma is a common chronic condition that is estimated to affect
339 million people worldwide1,2. Despite major advances in
asthma treatment and the availability of both global2 and national
guidance, asthma continues to cause a substantial burden in
terms of both direct and indirect costs1. In 2016, estimated
worldwide asthma deaths were 420,0001 and although there have
been falls in some countries over the last decade, significant
numbers of avoidable deaths still occur3. Mortality rates vary
widely, with low- and middle-income countries faring worse4. For
example, Uganda’s reported mortality rate is almost 50% higher5
than that reported globally (0.19/100,000)6, although inter-country
comparisons using different data sources and epidemiological
methodologies have limitations. The World Health Organisation
(WHO) has a global ambition for universal healthcare coverage by
2030 as millions of people worldwide do not have accessible
affordable medical care7. The WHO moreover recognises that
health systems with strong primary care have the utmost potential
to deliver improved health outcomes, greater efficiency and high-
quality care7. Perversely the availability of good quality primary
and social care tends to vary inversely, those having the greatest
needs being least likely to receive it8.
In addition to the issues of access and the quality of care, both
under- and over-diagnosis of asthma is common in all healthcare
settings, but the issue is of particular concern in primary care,
where most initial diagnoses are made9,10.
For people with asthma, high-quality, local and accessible
primary care could be a solution to poor control11. Our aim was to
identify the factors that experts believe enable the delivery of
high-quality asthma care and to review the evidence that confirms
that these factors do indeed have positive outcomes in
primary care.
RESULTS
Key drivers and their underpinning components
The expert panel identified five key drivers for the delivery of
quality respiratory care in primary care and a number of
components underpinning each of these drivers. These are
summarised in Table 1.
Of the 50 articles selected from the review, there were
comparatively smaller numbers of publications relating to the
impact of National Health Policy and Guidelines. However, there
was more substantial evidence relating to the other three key
drivers, which is summarised in tabular format (Tables 2–4).
National Health Policy
The expert panel reached an agreement that the political will to
prioritise asthma and to support both primary care and respiratory
disease were fundamental elements for the achievement of a
sustainable change. In their opinion this required national and
local programmes supporting the improvements. There was
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however little evidence published to support this opinion with
respect to patient outcome as it is not the area of research that is
commonly undertaken. A review of seven national European
asthma programmes to support strategies to reduce asthma
mortality and morbidity concluded that national/regional asthma
programmes are more effective than conventional treatment
guidelines12. One of the most well-known and successful national
programmes in Europe, which has resulted in reduced morbidity
and mortality and decreased costs, is the Finnish National Asthma
Programme13. Programmes outside of Europe have also demon-
strated the impact that prioritisation of primary care can have on
respiratory outcomes. Changing structures and policies in South
Africa and in Brazil may start to impact on primary care13,14.
Guidelines
Few studies have explored the extent of adherence to guidelines
for asthma management based on data provided directly by GPs.
One study aimed to evaluate adherence to GINA guidelines and its
relationship with disease control in real life. According to GINA
guideline asthma classification, the results indicated overtreat-
ment of intermittent and mild persistent asthma, as well as a
general poor adherence to GINA treatment recommendations,
despite its confirmed role in achieving a good asthma control15. In
the US, nationally representative data showed that agreement
with and adherence to asthma guidelines was higher for
specialists than for primary care clinicians, but was low in both
groups for several key recommendations16.
Reward for performance
Pay-for-performance (P4p) schemes are those that remunerate
physicians for achieving pre-defined clinical targets and quality
measures—so based on value—that contrasts to schemes that are
simply a fee-for-service payment, which pay for volume of activity
(Data from Review Table 2). In the UK, primary care has moved
towards group practices with P4p compensation in which
performance is measured using several defined quality indica-
tors17,18. A systematic review of 94 studies showed increased
practice activity but only limited evidence of improvements in the
quality of primary care or cost-effectiveness, despite modest
reductions in mortality and hospital admissions in some
domains18. In another review of seven studies from the US and
UK, the effects of financial incentive schemes were found to
improve patient’s well-being, whilst the effects on the quality of
primary healthcare were found to be modest and variable19.
An evaluation of three primary care incentive models, namely a
traditional fee-for-service model, a blended fee-for-service model
and a blended capitation model, demonstrated that the quality of
asthma care improved over time within each of the primary care
models20. The model that combined blended fee-for-service with
capitation appears to provide better quality care compared to the
traditional fee-for-service model in terms of outcome indicators
such as a lower rate of emergency department visits.
A P4p programme in the Netherlands containing indicators for
chronic care, prevention, practice management and patient
experience was designed by target users21. A study of 65 practices
that implemented the programme showed a significant improve-
ment in the mean asthma score after 1 year. It showed that a
bottom-up developed P4p programme might lead to improve-
ments in both clinical care and patient experience.
Practice resources and organisation
Optimal patient care requires targeted and tailored management
(Data from Review Table 3). The experts felt that the organisation
of both the GP practice and the local healthcare system had an
influence on the provision of high-quality care. Registered patient
lists and fully integrated computer systems were its foundation.
An approach called SIMPLES—developed in the UK, incorporated
into a desktop reference tool by the International Primary Care
Respiratory Group and adapted for use in the Netherlands22,23—
identifies patients who have uncontrolled symptoms or difficult-
to-manage disease and addresses preventable or treatable factors
to guide their management. Electronic alerts in patient records
have also been used to identify those at increased risk of an
exacerbation, in order to modify care and treatment24–26.
A systematic review of the effectiveness of computerised
clinical decision systems (CCDS) in the care of patients with
asthma demonstrated improvements in healthcare process
measures and patient outcomes27. Conversely another systematic
review focussing on their implementation in practice concluded
that the limiting factors were the lack of their regular use by
healthcare practitioners (HCPs) and adherence to the advice
offered28. These reviews both concluded that CCDS have the
potential to improve patient outcomes, practice efficiency and
produce cost-saving benefits if implemented27,28.
Computerised systems linked with internet programmes to
monitor asthma control can also afford benefits for patients. One
study identified that the use of both weekly internet-based self-
monitoring using the Asthma Control Questionnaire (ACQ) and
treatment adjustment using an online management tool resulted
in significant improvements in ACQ29.
Clinical prediction models could theoretically aid the diagnosis
of asthma in primary care but supportive evidence is currently
lacking30. However, there is strong evidence that service models
aimed at supporting primary care practitioners with the diagnosis
Table 1. Key drivers and their underpinning components identified
by the expert panel.
1. National healthcare policy
− Appropriately resourced primary care services
− Actions to support universal health coverage
− Recognition of importance of non-communicable chronic
disease management
− Balance between public and private insurance: healthcare
systems
− Redistribution of funding from hospitals to primary care
2. Clinical guidelines
− Recognition that primary care uses multiple disease guidelines
− Primary care ownership and succinct evidence-based guidelines
− Accessible guidelines produced in a standard recognised format
− Consider shifting to symptom-based guidelines
3. Reward for performance
− Recognition and rewards for high-quality respiratory practice
− Clearly defined financial incentive schemes
− Reward for the practice not individual practitioners
− Reimbursement policies aligned to guidelines, including
prescribing
4. Practice resources and organisation
− Registered patient lists and fully integrated computer systems
− Clinical care pathways
− Access to high-quality lung function and other diagnostic tests
− Access literacy and culturally sensitive patient education
5. Workforce
− Specialist asthma training programmes in primary care
− Dedicated and appropriately asthma-trained personnel
− Collaborative working across the wider primary healthcare team,
with defined roles
− Excellent interdisciplinary communication processes
MJ Fletcher et al.
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Table 3. Evidence summary to support practice resources and organisation.
Practice resources and
organisation
Country(Reference) Study type Description and study outcomes
Registered pt lists and fully
integrated computer systems
AND Clinical care pathways
UK22 Questionnaire; no data SIMPLES, a structured PC approach to
reviewing pts with uncontrolled asthma—
encompassing pt education monitoring,
lifestyle/pharmacological management and
addressing support needs. Involves close
cooperation between PC and SC. Outcomes:
No data available.
Registered pt lists and fully
integrated computer systems
AND Clinical care pathways
NL23 Questionnaire; no data SIMPLES adapted using a modified e-Delphi
approach to assess the stakeholder opinion.
Outcomes: Nine-component questionnaire—
a robust and holistic approach for difficult-to-
manage asthma. No data available.
Registered pt lists and fully
integrated computer systems
UK24 Cluster-randomised trial in 29 PC practices
with 911 at-risk asthma pts
Pilot study showed that PC intervention for
targeted at-risk asthma patients had the
potential for improving practice level
management and reducing asthma
emergency admissions.
Registered pt lists and fully
integrated computer systems
UK25 Pragmatic, 2-arm, RCT; 270 PC practices
covering >10,000 registered ‘at-risk
asthma’ pts
Aimed to determine whether the creation
and integration of at-risk asthma registers
into PC reduces asthma-related crisis events
for at-risk pts over a 12-month period
compared to control practices. Outcomes: No
data available.
Registered pt lists and fully
integrated computer systems
UK26 Retrospective study; 26 at-risk asthma pts
and 26 matched controls for 1 year pre-
and post-intervention
Implementation/service use costs estimated
before and 1 year after introduction of an at-
risk register. More ‘at-risk’ than control pts
were hospitalised/attended A&E/nebulised
for asthma; also used out-of-hours services/
attended GP/received OCS (all p < 0.025).
Outcomes: After register introduction, no at-
risk pts were admitted or attended A&E.




Systematic review of 19 studies
representing 16 RCTs (2003–2013)
evaluating CCDS for pts with asthma
and COPD
Use of CCDS improved asthma and COPD
care in 14 of the reviewed studies (74%).
There was considerable improvement in
healthcare process measures and clinical
outcomes. The effect on workload, efficiency,
safety, costs, provider and pt satisfaction
remain understudied.




Systematic review of 8 RCT CCDS
(1990–2012) for professional asthma
management
Use of CCDS by HCPs was found to be low,
and adherence to the advice was limited.
Concluded, if used, CDSS could result in
closer adherence to guidelines and improve
some clinical outcomes. Better alignment to
clinical workflow would enhance their use.
Registered pt lists and fully
integrated computer systems
NL29 1-year RCT; 200 adults (18–50 years) with
mild–moderate persistent asthma
Pt groups: (i) weekly asthma control
monitoring via online ACQ, treatment
adjusted via self-management algorithm
supervised by an asthma nurse specialist; (ii)
usual care. Outcomes: Weekly self-
monitoring/treatment adjustment led to
improved asthma control in pts with partly/
uncontrolled asthma at baseline.
Access to high-quality lung
function testing and other
diagnostic tests
Unknown at present30 Protocol: This will be a systematic review Clinical prediction models can be used to aid
PC asthma diagnosis by estimating outcome;
models combine ≥2 predictors, e.g. clinical
history/physical examination/test results/
treatment response. Outcomes: No data
available.
Access to high-quality lung
function testing and other
diagnostic tests
NL31 Observational study An online support system to advise GPs on pt
diagnosis and treatment. Spirometry
performed by local GP laboratory; spirometry
results, pt history questionnaire, ACQ and
CCQ reviewed online by pulmonologist; who
advises GP online, supported by a guideline-
based algorithm. Outcomes: Number of pts
MJ Fletcher et al.
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or ongoing monitoring of patients result in improved accuracy
and patient outcomes31–33.
Workforce
The expert panel felt that having access to dedicated and
appropriately trained personnel preferably as part of multi-
disciplinary teams was essential (Data from Review Table 4). This
need was accentuated because of increasing GP workloads and a
shortage of primary care physicians in many countries.
There was extensive evidence34–40 that a variety of models
involving a range of healthcare practitioners within both the core
primary healthcare team and extended community teams
improve patient outcomes and healthcare process measures—
such as an increased use of asthma action plans, improved
medication adherence36,39—and reduces the use of emergency
care34,38.
One approach in Canada is based on using primary care
networks, in which additional non-physician healthcare providers
are funded to help provide coordinated healthcare34. In these
networks patients were shown to be less likely to visit the ED than
patients in practices that were not part of the network.
Evidence from a range of countries supports the beneficial role
of pharmacists, working alone or in teams36–38. In a study utilising
community pharmacists to review patients with either poorly
controlled asthma or no recent asthma review, there were benefits
in terms of asthma control, inhaler technique, action plan
ownership, asthma-related QOL and medication adherence36.
The pharmacists were able to recruit patients and incorporate this
as part of daily practice. Availability of referral to a physician was
an important component of the service.
Evidence also indicates that education delivered by a variety of
methods enhances the quality of care delivered and improves
patient outcomes41–45. Approaches integrating education with
other interventions, such as the Colorado Asthma Toolkit
Programme (CATP) that combines education with decision
support tools, electronic patient records and other online support
materials, have been shown to have positive outcomes41,42.
Another team-based approach that combined an educational
intervention with the integration of an electronic clinical quality
management system with a reminder system found that the
number of action plans increased significantly39.
Patient education is an important factor for the improvement of
self-management and asthma control. An educational programme
from Australia demonstrated that patients who received person-
centred education had improved asthma outcomes compared to
those receiving a brochure only46. One review paper47 about
patient enablement concluded that HCPs need to develop their
understanding of this concept to integrate this into practice as the
level of this is linked to better patient outcomes.
DISCUSSION
Primary care is pivotal to any health system; however, there is no
universal definition of what we mean by primary care and
certainly not one standardised model of care. Without focussing
on a single model, we have attempted to bring together expert
opinion and the most recent evidence on strategies that improve
outcomes in asthma patients in primary care. To our knowledge
the methodology used in this project has not been used before.
The panel of experts who identified the key drivers were
knowledgeable of asthma in primary care at a national level in
their respective countries and globally. A literature search to
investigate the individual key drivers and their underpinning
components was undertaken using a keyword search. This
identified many publications but very few measured the effect
on patient outcome and those that did reported conflicting
results. Furthermore, we found a paucity of research relating to
the components relating to national healthcare policy and
guidelines.
The evidence suggests that health systems that have primary
care as a cornerstone and place asthma as a healthcare priority
improve asthma care and improve outcome on patient level. The
highly regarded Finnish asthma initiative carried out more than 25
years ago not only identified asthma as a national priority, but also




Country(Reference) Study type Description and study outcomes
with unstable asthma (ACQ ≥ 1.5) dropped
from 245 to 137.
Access to high-quality lung
function testing and other
diagnostic tests
NL32 PC Diagnostic Centre study. 156 pts
randomly selected from asthma/COPD-
service referrals
Five respiratory specialists assessed
spirometry data and pt histories. Facilities
developed to provide spirometry testing by
specially trained clinicians. GPs reluctant to
perform or interpret spirometry themselves
may be supported diagnostically by
respiratory specialists in an asthma service
although the reliability of this advice varies.
Access to high-quality lung
function testing and other
diagnostic tests
UK33 PC study; 678 pts aged 4–80 years with
first FeNO assessment at index date
FeNO use to guide ICS initiation/dosing
decisions and identify poor adherence. In the
year following index date, FeNO use was
evaluated in 2 pt cohorts to: (i) identify
steroid-responsive disease; (ii) guide asthma
management. Outcomes: Algorithms to guide




No studies found via search
ACQ Asthma Control Questionnaire, A&E Accident and Emergency department, AU Australia, CCQ Common Cold Questionnaire, CDDSS Computerised Clinical
Decision Systems, COPD chronic pbstructive pulmonary disease, DK Denmark, ES Spain, FeNO Exhaled Nitric Oxide Test, GP General Practitioner, HCP healthcare
practitioner, ICS inhaled corticosteroid, NL Netherlands, PC primary care, PTS patients, RCT randomised clinical trial, SC secondary care, UK United Kingdom, US
United States.
MJ Fletcher et al.
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Table 4. Evidence summary to support workforce issues.
Workforce Country Study type Description and study outcomes
1, 2, 3 CA34 Retrospective database study, adults. 2008–2009. PC
physician/network visited (n= 1,502,916); usual care
(n= 1,109,941)
PC networks designed to facilitate access to interprofessional,
team-based care, using AHPs skills in providing coordinated
healthcare. Health outcomes associated with PC networks
compared with conventional PC. Outcomes: Pts in network
practices less likely to visit ED for conditions such as asthma; fewer
ED visits and shorter hospital stays.
1, 2, 3 US36 Implementation study. 42 pharmacies, 2419 pts and 1284
provider interventions
Community pharmacist reviews of pts with poorly controlled
asthma/no recent physician asthma review; physician referral was
a service component. Outcomes: Benefits in asthma control,
knowledge, inhaler technique, AAP ownership, ARQOL, and
adherence.
1, 2, 3 AU37 A pragmatic cluster-randomised trial 96 pharmacists,
570 pts
Community-based asthma service by specially trained pharmacists:
3 vs. 4 visits in 6 months (12-month follow-up). Outcomes:
Clinically important outcomes in both groups with minimal
intervention, 3-visit service feasible/effective to implement, with
12-month review.
1, 2, 3 US38 Prospective pre-post study of pts receiving intervention
for 9 months; 126 pts
Pts received physician−pharmacist collaborative management in
PC. Pharmacists provided AAP/education/physician referral as
necessary. Outcomes: Asthma-related ED visits decreased by 30%
in the 9 months.
1, 2, 3 US39 5 community-based clinics
Retrospective pre- and post-intervention analysis
A team-based education approach involving an electronic clinical
quality management system; reminders/provision of AAPs by
nurses. Outcomes: Increased AAPs prescribed, pt outcomes were
not measured.
2, 3 UK40 Community-based, randomised, open-label
pragmatic study
SLS; a collaboration between physicians, nurses, hospital staff and
pharmacists linked using electronic pt health record, improving
HCP communication. Outcomes: Improved asthma control (ACT
increase).
2, 3 BR44 Implementation study 132 PC physicians & nurses
Aim to decrease number of respiratory-related (Asthma/
COPD) referrals
Educational intervention (matrix support, evaluated in PC):
physicians/nurse training/support from specialists (e.g. tailored
education/joint consultations/case discussions). Outcomes:
referrals decreased by >50% from 13.4 to 5.4 cases/month (P=
0.09). An effective tool to improve asthma knowledge and
promote changed PC/SC relations. Pt outcomes not measured.
4 US41 Implementation study. 57 practices, 15,508 pts
Pre-post
CATP; a provider-level intervention to improve guideline use and
asthma care (education and pt resources). Outcomes: CATP
improved guideline care processes but not pt outcomes, of
practices: 40.4% increased ICS use, 53.2% increased AAP use; 78.7%
initiated/increased spirometry use.
4 US42 Implementation study (asthma pts 5–64 years) 12 months
pre- and post-CATP implementation 9 practices; 2678 pts
Compared 12 months pre- and post-use of the CATP in PC practice.
Outcomes: An improvement in asthma quality processes—
increase in rate of asthma severity measurement and medication
management, no change in outcomes across multiple domains:
exacerbations, utilisation, symptom scores, and pulmonary
physiology measures.
4 CA43 Pragmatic improvement study. 23 physicians, 25 AHPs;
12-month pre/post-intervention knowledge
Mentorship-based intervention with interactive education/hands-
on training/ unstructured peer mentoring. Aimed to address PC
underuse/quality of spirometry. Outcomes: Improved spirometry
test acceptability, poor overall spirometry usage (remained < 40%),
health outcome effects not measured.
5 DK35 Consultation guide based on GINA guidelines Consultation included symptom evaluation, treatment,
compliance, lung function, scheduled follow-up appointment
based on asthma control level. Outcomes: Asthma control
improved when a systematic asthma management approach was
introduced/applied by dedicated nurses.
5 ES45 Cluster controlled implementation study 57 practices 400
PC physicians and nurses, 6/12 pre−post-intervention 7
control
GP practices received an education programme for use of
respiratory health status tools. Outcomes: In intervention practices
slight improvement in pts with a record of a health status score
(ACT, CAT and/or mMRC), but absolute % score recorded was still
relatively low (1.70%), even after intervention. No differences in
clinical outcomes.
5 AU46 RCT aged ≥55 with asthma
N= 58 intervention group
n= 56 control group
Groups: brochure only (controls); person-centred education
(intervention). Outcomes: Intervention pts had improved asthma
control, adherence, AAP ownership, ARQOL and exacerbations
over 12 months vs. control pts.
MJ Fletcher et al.
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the key role of General Practitioners and nurses and greatly
reduced asthma mortality and morbidity48. After the successful
implementation of the Finnish asthma plan, many other countries
and regions have attempted to implement similar initiatives13,14.
For example, in Poland and Brazil, asthma burden was reduced
utilising such a strategy49.
Poor health outcomes in asthma patients have been attributed
in primary care to gaps between evidence-based recommenda-
tions and practice50,51. Studies show that adherence to clinical
guidelines is poor, whatever the clinical setting, with the main
barriers being time pressures and limited resources52, reflecting
that it is not the guidelines per se that improve care, but it is the
implementation of the recommendations.
Most guidelines are complex, lengthy and generally biased
towards a secondary care perspective. The Global Initiative for
Asthma (GINA) committee acknowledges the difficulty of imple-
menting their recommendations in primary care, but they are
almost exclusively developed by tertiary care physicians2. In the
Netherlands, the Dutch Royal Society of General Practitioners
writes its own guidelines, which are all presented in the same
recognisable brief format. Their asthma guidelines were first
published in 1986 with revisions every 4 years and are relatively
well followed53. However, there are now 194 different clinical
guidelines in the Netherlands, illustrating just how difficult it is for
General Practitioners to adopt all the recommendations of each
clinical guideline and its update.
A survival analysis of guidelines has concluded that 86% are still
up to date 3 years after their publication and yet the median
lifespan of a clinical guideline is about 60 months54. New evidence
is continually emerging and this implies that regular updates of
clinical guidelines are necessary55,56. It is therefore important that
all guidelines have a process for regular scrutiny57 and are
updated for contemporary applicability. Indeed, asthma and COPD
guidelines published by the Association of Scientific Medical
Societies in Germany and the Asthma Guidelines of the German
Respiratory Society are regularly updated, at least every 5 years
(more frequently as necessary); if not they are deleted from the
website.
The proliferation of guidelines and their asynchronicity can
result in conflicting recommendations. For example, in the UK,
four asthma guidelines could be followed (the GINA Report, British
Thoracic Society and Scottish Intercollegiate Guidelines (BTS) and
the NICE recommendations next to local guidelines)2,58,59, none of
which are fully aligned. A review of three contemporaneous
international guidelines updated in 2012 (The Canadian Thoracic
Society (CTS), BTS and GINA) also revealed significant
inconsistency arising from varying approaches to evidence
interpretation and recommendation formulation60.
Globally, there is a move away from pure fee-for-service
payments towards primary care payment schemes linked to
performance, which recognise and reward good practice to
improve quality and reduce costs61. These schemes combine
quality standards and targets but still tend to be process driven,
not outcome based. The evidence for the effectiveness of such
schemes in general on improving quality of care is both
inconclusive and inconsistent62.
The UK quality and outcomes framework (QOF), which includes
asthma, is the world’s largest primary care payment for
performance (P4p) scheme63. Evidence however shows that
improved patient outcomes may not be sustained, cost reduction
is unproven18 and leads to increased GP activity, but this does not
necessarily correlate with improved individual patient benefit64,65.
Furthermore, in Portugal, the recording of asthma and COPD
prevalence as performance indicators in pay-for-performance
contracts showed a modest but steady increase over time in
physician’s diagnosis and ICPC-2 coding of these two conditions,
but no direct patient benefits66.
Disease-specific schemes are usually aligned to clinical guide-
lines and some focus on prescribing. In Norway, under such a
scheme, combination asthma medications were only reimbursed
for patients diagnosed with asthma. As a result, asthma diagnosis
significantly increased67.
The effect on health inequalities has also been studied. The
results from UK QOF have shown that the gap between
achievements from practices in the most deprived and least
deprived areas narrowed68. Nevertheless, inequalities in morbidity
and premature mortality persisted69,70. Additionally incentives can
increase inequalities because those conditions that are ‘incenti-
vised’ are afforded greater priority and resource allocation, to the
detriment of those that are not71.
It would appear that simplistic fee-for-service schemes based
purely on an activity—such as performing spirometry tests—
which are not part of reimbursement of a more comprehensive
assessment, have the potential to inadvertently lead to an
increase in unnecessary tests. Pay-for-performance schemes have
the potential to improve asthma care, but will be reliant on the
specifics of the scheme and the quality indicators applied. They
can be useful as part of a wider programme to raise quality and
afford benefits over rewarding fee-for-service activity.
Appropriate practice organisation and systems focussing on the
identification, diagnosis and treatment are pivotal for quality
asthma care. There was compelling evidence to indicate that
integrated, multi-faceted practice-based approaches for the
Table 4 continued
Workforce Country Study type Description and study outcomes
5 Global47 Literature review of 24 studies Reviewing conceptualisation/practice in PC. Enablement
influenced by: open communication style/longer consultations/pt
centredness of HCP. Outcomes: 2 RCTs suggest enablement linked
to better pt outcomes.
5 DE85 5-year programme 2006–2010. N= 109,042 in year 5 German asthma management programme. Outcomes: Enhanced
care quality; improved symptoms/adherence/pharmacotherapy/
hospitalisation.
1=Dedicated and appropriately asthma-trained personnel; 2= Collaborative working across the wider Primary HealthCare Team, with defined roles; 3=
Excellent interdisciplinary communication processes; 4= Specialist asthma training programmes in PC; 5=Dedicated and appropriately asthma-trained
personnel.
AAP asthma action plan, ACT Asthma Control Test, A&E Accident and Emergency department, AHP Allied Health Practitioner, ARQOL asthma-related quality of
life, AU Australia, BR Brazil, CA Canada, CAT COPD Assessment Test, CATP Colorado Asthma Toolkit Programme, COPD chronic obstructive pulmonary disease, DE
Germany, DK Denmark, ED Emergency department, ES Spain, GINA Global Initiative for Asthma, GP General Practitioner, HCP healthcare practitioner, mMRC
Modified Medical Research Council, PC primary care, PTS patients, RCT randomised clinical trial, SC secondary care, SLS Salford Lung Study, UK United Kingdom,
US United States.
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management of patients improves outcomes and reduces the
need for referral to secondary care22,25,72. Coordinated practice
systems that combine several interventions such as decision
support tools, flagging of electronic records, use of care pathways,
staff training and structured approaches to patient education, if
consistently implemented, afford the greatest benefits. Imple-
mentation of practice schemes is likely to be enhanced where
there is dedicated clinical and administrative leadership.
Intuitively an accurate diagnosis should lead to better patient
outcomes, although we found conflicting evidence that access to
proper diagnosis has an impact on patient outcomes33,73. Never-
theless, an accurate diagnosis remains the fulcrum on which optimal
asthma management depends. Indeed programmes in which an
expanded medical team improved the quality of asthma care within
the primary care setting (such as a diagnostic and management
support organisation) show clear benefit on patient outcome32.
Spirometry combined with an assessment of reversibility has been
set as gold standard for asthma diagnosis2. However, standards on
quality of spirometry such as those set by the ERS and ATS are often
not achieved74–76 and impose an unnecessarily high and potentially
unachievable threshold in primary care73. Nevertheless, some
studies have demonstrated that primary care office spirometry can
meet the acceptability criteria77–79. Although such standards are
laudable particularly in a specialist setting, their practicability in
primary care, where patients commonly have mild–moderate,
intermittent disease, is debatable. The latest ATS-ERS spirometry
guidelines (published in October 2019) may address some of these
issues.80 However, the use of spirometry in the diagnosis of asthma
remains beyond reach in primary care around the world.
In many countries primary care physicians have limited or no
access to tests of lung function or airway inflammation. The creation
of diagnostic hubs in the community may open access to these
tests32. A structured approach to diagnosis including applicability
and feasibility for primary care is currently under development by an
ERS taskforce; its outcome not available at the time of writing.
With rising clinical workloads, increasing clinical complexity and
in many countries a shortage of trained primary care physicians,
multi-professional teamworking is increasingly important.81,82 This
is accentuated by the expectation for primary care to manage
patients with chronic illness.
In many parts of the world, appropriately asthma-trained
personnel, such as primary care nurses, are key to the delivery
of high-quality asthma care. Dedicated nursing staff can offer
continuity to patients, providing education and routine follow-
up35. Evidence supports the concept that pharmacists working
alone or in teams in collaboration with GPs are an accessible asset
for the effective management of asthma and can positively
influence asthma outcomes36.
Healthcare practitioner education is pivotal and the need for
guideline-focused training in primary care is well established82.
The literature seems to support this viewpoint but in many studies
the effect on outcome has not been adequately considered,
highlighting a need for more outcome-focussed research.
Healthcare systems faced with the challenge of moving the care
of people with long-term conditions such as asthma from
established specialist services to primary care should consider
implementing collaborative educational strategies44. Matrix-
support collaborative care that includes training and support for
primary care physicians/nurses from specialists, including joint
consultations, case discussions and tailored education, has been
shown to be well-accepted by primary care professionals and was
associated with improved knowledge and reduced respiratory
secondary care referrals44. A scoping exercise and literature review
of the effectiveness of educational interventions in either
changing health professional practice or in improving health
outcomes was commissioned by The International Primary Care
Respiratory Group (IPCRG)83. The impact of education interven-
tions on their own was inconclusive, although there was some
evidence of effectiveness when they are combined with other
quality improvement strategies or incentives83.
Asthma continues to be a substantial cause of morbidity and
mortality worldwide and there is need for a coordinated effort to
improve care. A well-resourced primary care service is central to
the provision of accessible and effective asthma care. An expert
team identified the drivers that could enable improvements in
both clinical management and patient outcomes, and a literature
search showed that each of these individual drivers is supported
by varying degrees of evidence. Objectively assessing the
outcomes of such interventions is challenging because studies
in this area are inherently complex, difficult to undertake and
resource intensive, and so definitive research is seldom under-
taken. In contrast single interventions studies are easier to
conduct but frequently methodologically less robust and there-
fore tend to be inconclusive. Nevertheless, if substantial improve-
ments in the management of asthma in primary care at a global
level are to be achieved, combinations of interventions appear to
be most effective. Well-supported holistic interventions involving
the entire healthcare system and including the patient voice
appear to provide the best outcomes.
METHODS
Expert panel
An expert panel of 12 primary care global asthma experts—ten
General Practitioners and two specialist nurses—was convened in
Amsterdam. An initial teleconference between the panel preceded
the meeting to gather ideas. The expert panel undertook a
brainstorming exercise as part of a force-field analysis in order to
reveal their ideas and experience regarding drivers of successful
management of asthma in primary care84. A force-field analysis
can be used to determine the forces (factors) that may prevent
change from occurring and to identify those that cultivate change.
During the brainstorming session, the experts were divided into
facilitated groups to discuss the relative importance of the drivers
and identify the factors which underpin each of them. Results
were analysed thematically and circulated after the meeting for
comment and agreement.
Literature review
To identify whether evidence existed for the drivers and factors
identified by the expert panel, literature was searched from
PUBMED using the terms asthma and primary care in combination
with other terms listed in Table 5. Proposed search terms were
combined using Boolean operators. The initial search was limited
Table 5. Combinations of keywords used in PubMed search.
Asthma AND primary care; n= 6535
Asthma and primary care AND outcomes; n= 1502
Management of asthma in primary care AND outcomes, n= 821
Asthma AND primary care AND outcome AND improvement; n= 1728
Asthma AND primary care AND team building; n= 14
Asthma AND primary care AND team; n= 274
Asthma AND primary care AND incentives; n= 105
Asthma AND family practice AND outcome AND improvement in
adults; n= 28
Asthma AND general practice AND outcome AND improvement in
adults; n= 62
Asthma AND family practice AND adults; n= 950
Asthma AND general practice; n= 622
Asthma AND quality improvement; n= 455
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to papers published in English over the last 10 years and studies in
adults aged over 18 years old. The experts were also asked for
additional papers and in addition, more articles were identified
from the references from the selected papers. Papers identified
were subsequently screened for eligibility by MF and TM (Fig. 1). A
total of 171 were included in the summary table of which 50
papers were identified as having evidence for the factors
identified by the panel.
DATA AVAILABILITY
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